- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.06. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 4 | Oslo Børs | ||
| 17.06. | Circio Holding ASA - Funding requested under financing commitment from Atlas | 1 | Oslo Børs | ||
| 17.06. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 1 | Oslo Børs | ||
| 16.06. | Circio Holding ASA: TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025 | 1 | Oslo Børs | ||
| 16.06. | CIRCIO: TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025 | 2 | Cision News | ||
| 06.06. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 10 | Oslo Børs | ||
| 05.06. | Circio Holding ASA: Minutes from the annual general meeting 2025 | 7 | Cision News | ||
| 28.05. | Circio presents new and differentiating circVec data and corporate update in live webcast | 2 | Cision News | ||
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 27.05. | Circio Holding ASA - Updated information to the notice of annual general meeting 2025 - Reverse share split and share capital decrease | 1 | Cision News | ||
| 22.05. | Circio Holding ASA: Circio invites to R&D and corporate update webcast on 28 May 2025 | 2 | Oslo Børs | ||
| 22.05. | Circio invites to R&D and corporate update webcast on 28 May 2025 | 1 | Cision News | ||
| 15.05. | Circio Holding ASA - Notice of annual general meeting 2025 | 1 | Cision News | ||
| 15.05. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 2 | Oslo Børs | ||
| 14.05. | Circio Holding ASA: Atlas Holdings for CIRCIO | 2 | Oslo Børs | ||
| 14.05. | Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025 | 1 | Cision News | ||
| 13.05. | Circio Holding ASA - Funding requested under financing commitment from Atlas | - | Oslo Børs | ||
| 06.05. | Circio Holding ASA: Circular RNA innovator Circio to present strengthened circVec gene therapy data at ASGCT 2025 | 2 | Oslo Børs | ||
| 06.05. | Circular RNA innovator Circio to present strengthened circVec gene therapy data at ASGCT 2025 | 1 | Cision News | ||
| 30.04. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 5 | Oslo Børs | ||
| 16.04. | Circio Holding ASA - Funding requested under financing commitment from Atlas | 1 | Oslo Børs |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 7,138 | -0,81 % | Aktienmarkt: Evotec-Aktie kann sich nicht behaupten (6,38 €) | An der deutschen Börse liegt das Wertpapier von Evotec aktuell im Minus. Das Wertpapier notiert zur Stunde bei 6,38 Euro. Am Aktienmarkt liegt die Aktie von Evotec gegenwärtig im Minus. Die Aktie verbilligte... ► Artikel lesen | |
| MEDIGENE | 0,125 | -10,71 % | BRISANTE Meldung setzt Medigene Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
| PAION | 0,011 | -27,03 % | Paion Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| VALNEVA | 2,420 | -0,49 % | Valneva überträgt Impfstoffvertrieb in Deutschland an CSL | Valneva SE hat mit CSL Seqirus eine exklusive Vereinbarung über die Vermarktung und den Vertrieb seiner drei Impfstoffe in Deutschland geschlossen. Die Kooperation startet im Juli 2025 mit dem Chikungunya-Impfstoff... ► Artikel lesen | |
| NOVAVAX | 5,424 | -0,40 % | Novavax Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| INOVIO PHARMACEUTICALS | 1,840 | +1,10 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen | |
| BAVARIAN NORDIC | 22,640 | -0,70 % | Bavarian Nordic A/S: Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women | First studies to evaluate MVA-BN in infants under 2 years of age and pregnant and breastfeeding women.The multi-partner research project is aimed at expanding access to mpox vaccines for vulnerable... ► Artikel lesen | |
| INFLARX | 0,696 | -0,43 % | InflaRx N.V. - 6-K, Report of foreign issuer | ||
| VAXART | 0,433 | +2,90 % | Vaxart, Inc.: Vaxart Announces Preliminary Results of Annual Meeting of Stockholders | SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,770 | -2,75 % | RedHill Biopharma Ltd. - F-1, Registration statement for certain foreign private issuers | ||
| CYTODYN | 0,258 | 0,00 % | CytoDyn Inc.: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer | VANCOUVER, Washington, June 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential... ► Artikel lesen | |
| EMERGENT BIOSOLUTIONS | 5,592 | +3,14 % | Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US | ||
| TELIX PHARMACEUTICALS | 13,525 | -0,51 % | Telix Pharmaceuticals Limited: Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses | MELBOURNE, Australia and INDIANAPOLIS, June 25, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its Telix Manufacturing... ► Artikel lesen | |
| SINOVAC BIOTECH | - | - | Heng Ren Partners: Heng Ren Calls on Sinovac to Pay Shareholders the Special Dividend Before the July 8 Board Vote | BOSTON, June 16, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today sent an open resolution to Sinovac's shareholders outlining the... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 2,076 | +7,79 % | CytomX Therapeutics Inc.: CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA (pembrolizumab) in Patients with Metastatic Melanoma | SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that the... ► Artikel lesen |
Das Unternehmen CIRCIO HOLDING ASA kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,043 Euro und damit -0,92 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIRCIO HOLDING ASA finden Sie auf Wallstreet Online.